Sky Oak Wealth, LLC Greenwich Life Sciences, Inc. Transaction History

Sky Oak Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$21.76 - $39.43 $160,762 - $291,308	-7,388 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$31.24 - $53.6 $531 - $911	-17 Reduced 0.23%	7,388 $332,000
Q1 2021 Apr 29, 2021	SELL	$22.37 - $39.98 $15,636 - $27,946	-699 Reduced 8.63%	7,405 $293,000
Q4 2020 Feb 02, 2021	BUY	$3.48 - $72.22 $28,201 - $585,270	8,104 New	8,104 $296,000

1.01M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $173M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky Oak Wealth, LLC with notifications on news.